From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following Brexit

Mark P. Lythgoe*, Jonathan Krell, Mark Bower, Ravindhi Murphy, John Marriott, Sarah P. Blagden, Ajay Aggarwal, Richard Sullivan

*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following Brexit'. Together they form a unique fingerprint.

Medicine & Life Sciences